Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Revenues | 191.6 | 259.4 | 321.7 | 240.6 | 210.2 | 116.3 | 146.0 | 122.5 |
| Revenue growth | -26.1% | -19.4% | 33.7% | 14.5% | 80.8% | -20.4% | 19.2% | 195.5% |
| Cost of goods sold | 98.4 | 135.0 | 157.7 | 107.9 | 98.1 | 57.4 | 79.4 | 76.2 |
| Gross profit | 93.3 | 124.4 | 164.0 | 132.7 | 112.2 | 58.9 | 66.6 | 46.3 |
| Gross margin | 48.7% | 48.0% | 51.0% | 55.1% | 53.4% | 50.6% | 45.6% | 37.8% |
| Selling, general and administrative [+] | 47.6 | 47.3 | 50.8 | 32.1 | 30.3 | 24.8 | 29.0 | 19.0 |
| Sales and marketing | 24.4 | 24.9 | 25.3 | 17.6 | 17.2 | 14.0 | 16.3 | 10.3 |
| General and administrative | 23.3 | 22.4 | 25.5 | 14.6 | 13.1 | 10.9 | 12.8 | 8.7 |
| Research and development | 117.2 | 114.5 | 98.4 | 60.1 | 48.7 | 45.2 | 55.8 | 35.2 |
| Equity in earnings | | -1.1 | -3.3 | -0.8 | | | | |
| Other operating expenses | 1.2 | 2.3 | 2.6 | | | 0.0 | 2.7 | 2.6 |
| EBITDA [+] | -53.4 | -20.9 | 22.9 | 44.1 | 38.6 | -6.0 | -0.2 | 1.3 |
| EBITDA growth | 155.8% | -191.4% | -48.2% | 14.4% | -745.2% | 3732.1% | -112.0% | -120.0% |
| EBITDA margin | -27.9% | -8.1% | 7.1% | 18.3% | 18.3% | -5.1% | -0.1% | 1.1% |
| Depreciation | 7.3 | 8.1 | 5.5 | 4.4 | 3.8 | 3.5 | 12.0 | 6.7 |
| EBITA | -60.7 | -28.9 | 17.4 | 39.7 | 34.7 | -9.5 | -12.2 | -5.4 |
| EBITA margin | -31.7% | -11.2% | 5.4% | 16.5% | 16.5% | -8.1% | -8.3% | -4.4% |
| Amortization of intangibles | 12.1 | 11.9 | 8.4 | | 1.6 | 1.6 | 8.7 | 5.1 |
| EBIT [+] | -72.9 | -40.9 | 9.0 | 39.7 | 33.1 | -11.1 | -20.9 | -10.6 |
| EBIT growth | 78.3% | -555.3% | -77.4% | 19.9% | -398.5% | -46.9% | 98.0% | 40.1% |
| EBIT margin | -38.0% | -15.8% | 2.8% | 16.5% | 15.8% | -9.5% | -14.3% | -8.6% |
| Non-recurring items [+] | 25.1 | 1.7 | 0.9 | | | 2.4 | 115.8 | 21.4 |
| Asset impairment | 12.7 | | | | | 0.2 | 113.2 | |
| In-process research & development | | | | | | | 1.3 | 21.4 |
| Other income (expense), net [+] | 0.9 | -3.2 | 0.6 | 0.9 | 0.1 | 0.1 | 0.2 | 0.0 |
| Other | 0.9 | 1.6 | 0.6 | 0.9 | 0.1 | 0.1 | 0.2 | 0.0 |
| Pre-tax income | -97.0 | -45.8 | 8.7 | 40.6 | 33.3 | -13.3 | -136.4 | -31.9 |
| Income taxes | 1.1 | 20.4 | 4.2 | 14.1 | -31.4 | -0.1 | 0.0 | 0.0 |
| Tax rate | | | 47.9% | 34.6% | | 0.7% | 0.0% | |
| Net income | -98.1 | -66.2 | 4.5 | 26.6 | 64.7 | -13.2 | -136.4 | -32.1 |
| Net margin | -51.2% | -25.5% | 1.4% | 11.0% | 30.8% | -11.4% | -93.4% | -26.2% |
| |
| Basic EPS [+] | ($1.09) | ($0.73) | $0.05 | $0.31 | $0.86 | ($0.19) | ($2.01) | ($2.47) |
| Growth | 49.5% | -1525.9% | -83.4% | -64.3% | -554.8% | -90.6% | -18.5% | 48.8% |
| Diluted EPS [+] | ($1.09) | ($0.73) | $0.05 | $0.30 | $0.82 | ($0.19) | ($2.01) | ($2.47) |
| Growth | 49.5% | -1561.5% | -83.2% | -63.6% | -532.5% | -90.6% | -18.5% | 48.8% |
| |
| Shares outstanding (basic) [+] | 89.8 | 90.5 | 88.2 | 86.3 | 75.0 | 69.8 | 67.7 | 13.0 |
| Growth | -0.8% | 2.6% | 2.2% | 14.9% | 7.5% | 3.1% | 421.4% | 200.4% |
| Shares outstanding (diluted) [+] | 89.8 | 90.5 | 90.4 | 89.0 | 78.9 | 69.8 | 67.7 | 13.0 |
| Growth | -0.8% | 0.1% | 1.5% | 12.8% | 13.0% | 3.1% | 421.4% | 200.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|